Article
Focus on The 5-HT1A receptor: emerging role of a gene regulatory variant in psychopathology and pharmacogenetics.
The international journal of neuropsychopharmacology - 1 Dec 2004
Lesch Klaus Peter, Gutknecht Lise
Abstract excerpt
While multiple lines of evidence implicate the 5-HT1A receptor in the pathophysiology of anxiety and depression as well as in the mechanism of action of anxiolytics/antidepressants, its relevance to the therapeutic effectiveness of these drugs has been a matter of considerable debate (for review see Griebel, 1995; Hensler, 2003; Hjorth et al., 2000; Lesch et al., 2003). In the current issue of the International...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
